Literature DB >> 16330555

Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?

Hans-Jürgen Wester1, Horst Kessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330555

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  27 in total

1.  Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy.

Authors:  Dilani Chathurika Dehigaspitiya; Suryakiran Navath; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

2.  Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.

Authors:  Dana J Gary; Hoyoung Lee; Rahul Sharma; Jae-Sung Lee; Youngwook Kim; Zheng Yun Cui; Di Jia; Valorie D Bowman; Paul R Chipman; Lei Wan; Yi Zou; Guangzhao Mao; Keunchil Park; Brittney-Shea Herbert; Stephen F Konieczny; You-Yeon Won
Journal:  ACS Nano       Date:  2011-04-06       Impact factor: 15.881

3.  18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.

Authors:  Zhanhong Wu; Zi-Bo Li; Weibo Cai; Lina He; Frederick T Chin; Fang Li; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-05       Impact factor: 9.236

4.  Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer.

Authors:  Sebastian Knör; Sumito Sato; Timo Huber; Alfred Morgenstern; Frank Bruchertseifer; Manfred Schmitt; Horst Kessler; Reingard Senekowitsch-Schmidtke; Viktor Magdolen; Christof Seidl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-22       Impact factor: 9.236

5.  In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.

Authors:  Daniel J Rubins; Xiangjun Meng; Paul McQuade; Michael Klimas; Krista Getty; Shu-An Lin; Brett M Connolly; Stacey S O'Malley; Hyking Haley; Mona Purcell; Liza Gantert; Marie Holahan; Joel Lindgren; Pär Eklund; Caroline Ekblad; Fredrik Y Frejd; Eric D Hostetler; Dinko E González Trotter; Jeffrey L Evelhoch
Journal:  Mol Imaging Biol       Date:  2020-10-23       Impact factor: 3.488

6.  Methodology for labeling proteins and peptides with lead-212 (212Pb).

Authors:  Kwamena E Baidoo; Diane E Milenic; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2013-04-17       Impact factor: 2.408

7.  Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.

Authors:  C Andrew Boswell; Peter K Eck; Celeste A S Regino; Marcelino Bernardo; Karen J Wong; Diane E Milenic; Peter L Choyke; Martin W Brechbiel
Journal:  Mol Pharm       Date:  2008-06-07       Impact factor: 4.939

8.  Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.

Authors:  Bing Jia; Zhaofei Liu; Jiyun Shi; Zilin Yu; Zhi Yang; Huiyun Zhao; Zhengjie He; Shuang Liu; Fan Wang
Journal:  Bioconjug Chem       Date:  2007-12-11       Impact factor: 4.774

9.  Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule.

Authors:  Anna Orlova; Magdalena Malm; Maria Rosestedt; Zohreh Varasteh; Ken Andersson; Ram Kumar Selvaraju; Mohamed Altai; Hadis Honarvar; Joanna Strand; Stefan Ståhl; Vladimir Tolmachev; John Löfblom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-13       Impact factor: 9.236

10.  α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug.

Authors:  Nora Graf; Diane R Bielenberg; Nagesh Kolishetti; Christoph Muus; Jacqueline Banyard; Omid C Farokhzad; Stephen J Lippard
Journal:  ACS Nano       Date:  2012-05-14       Impact factor: 15.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.